NCT04879589View on ClinicalTrials.gov

Phase 1 Study of ATRS-2002 in Healthy Male Adults

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

September 1, 2022

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG

Abiraterone Acetate

ATRS-2002

Sponsors

Lead Sponsor

Collaborators (1)

Antares Pharma Inc.

All Listed Sponsors

collaborator

Antares Pharma Inc.

INDUSTRY

lead

Syneos Health

OTHER